<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40865109</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2590-7379</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>11</Day></PubDate></JournalIssue><Title>Biomedica : revista del Instituto Nacional de Salud</Title><ISOAbbreviation>Biomedica</ISOAbbreviation></Journal><ArticleTitle>Prevalence and characterization of human immunodeficiency virus coinfection in patients hospitalized with tuberculosis in a reference hospital in Bogot&#xe1;.</ArticleTitle><Pagination><StartPage>423</StartPage><EndPage>435</EndPage><MedlinePgn>423-435</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7705/biomedica.7664</ELocationID><Abstract><AbstractText>Introducci&#xf3;n. La tuberculosis es la principal causa de muerte en los pacientes con infecci&#xf3;n por el virus de la inmunodeficiencia humana. La coinfecci&#xf3;n de Mycobacterium tuberculosis y HIV es muy frecuente. Objetivo. Establecer la prevalencia de la infecci&#xf3;n por HIV en pacientes hospitalizados con tuberculosis, y determinar sus caracter&#xed;sticas y desenlaces. Materiales y m&#xe9;todos. Se realiz&#xf3; un estudio retrospectivo, de corte transversal, en pacientes con tuberculosis -pulmonar o extrapulmonar- y coinfecci&#xf3;n por HIV, hospitalizados en una instituci&#xf3;n de referencia de Bogot&#xe1; entre el 2019 y el 2021. Resultados. En el grupo de los 102 pacientes con tuberculosis, la prevalencia de infecci&#xf3;n por HIV fue del 52,3% (54). Entre estos 54, 24 pacientes (44,4%) tuvieron confirmaci&#xf3;n microbiol&#xf3;gica o histopatol&#xf3;gica de la tuberculosis y, 19 (35,2 %), infecci&#xf3;n por VIH de novo. En los 54 coinfectados, la mediana de la edad fue de 38 a&#xf1;os (RIC: 29-42). El 79,6 % (43/54) fueron hombres. La mediana del n&#xfa;mero de linfocitos T CD4+ fue de 59 c&#xe9;lulas/&#x3bc;l (RIC: 32-120), y el 72,2 % (39/54) ten&#xed;a menos de 200 c&#xe9;lulas/&#x3bc;l. El 31,4 % (17/54) de los pacientes con antecedente de infecci&#xf3;n por HIV recib&#xed;a terapia antirretroviral. En cuanto a la forma cl&#xed;nica, la tuberculosis fue pulmonar en el 51,9 % (28/54) y extrapulmonar en el 48,1 % (26/54) de los pacientes. La tuberculosis extrapulmonar fue men&#xed;ngea (29,6 %), miliar (12,9 %), pleural (3,7 %) y peritoneal (3,7 %). Hubo 33,3 % de mortalidad intrahospitalaria, asociada con el n&#xfa;mero de linfocitos T CD4+ (p &lt; 0,05), el diagn&#xf3;stico de novo de HIV (p &lt; 0,04) y la presencia de tuberculosis men&#xed;ngea (p &lt; 0,03). Conclusi&#xf3;n. La coinfecci&#xf3;n de Mycobacterium tuberculosis y HIV es frecuente y se relaciona con una inmunosupresi&#xf3;n avanzada, por lo que debe hacerse una b&#xfa;squeda activa de la infecci&#xf3;n con HIV en estos casos. La tuberculosis men&#xed;ngea fue la forma extrapulmonar m&#xe1;s frecuente y se asoci&#xf3; con mortalidad.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Puentes-Ariza</LastName><ForeName>Gean Carlo</ForeName><Initials>GC</Initials><Identifier Source="ORCID">0000-0002-7001-1157</Identifier><AffiliationInfo><Affiliation>Departamento de Medicina Interna, Facultad de Medicina, Universidad Nacional de Colombia, Bogot&#xe1;, D. C., Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mel&#xe9;ndez-Rhenals</LastName><ForeName>Sugeich</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4593-3125</Identifier><AffiliationInfo><Affiliation>Departamento de Medicina Interna, Facultad de Medicina, Universidad Nacional de Colombia, Bogot&#xe1;, D. C., Colombia; Servicio de Medicina Interna, Hospital Universitario Nacional de Colombia, Corporaci&#xf3;n Salud UN, Bogot&#xe1;, D.C., Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nocua-B&#xe1;ez</LastName><ForeName>Laura Cristina</ForeName><Initials>LC</Initials><Identifier Source="ORCID">0000-0003-2869-2339</Identifier><AffiliationInfo><Affiliation>Departamento de Medicina Interna, Facultad de Medicina, Universidad Nacional de Colombia, Bogot&#xe1;, D. C., Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe1;ez-Ardila</LastName><ForeName>Hugo</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-4690-9055</Identifier><AffiliationInfo><Affiliation>Servicio de Infectolog&#xed;a, Hospital Sim&#xf3;n Bol&#xed;var, Bogot&#xe1;, D.C., Colombia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Prevalencia y caracterizaci&#xf3;n de la coinfecci&#xf3;n por el virus de la inmunodeficiencia humana en pacientes hospitalizados con tuberculosis en un hospital de referencia de Bogot&#xe1;.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Colombia</Country><MedlineTA>Biomedica</MedlineTA><NlmUniqueID>8205605</NlmUniqueID><ISSNLinking>0120-4157</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="Y">HIV Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014376" MajorTopicYN="Y">Tuberculosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003105" MajorTopicYN="N" Type="Geographic">Colombia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="eng"><AbstractText Label="INTRODUCTION.">Tuberculosis is the leading cause of death in patients with human immunodeficiency virus infection; tuberculosis-HIV coinfection is highly prevalent.</AbstractText><AbstractText Label="OBJECTIVE.">To establish the prevalence of HIV infection in patients hospitalized with tuberculosis and determine their characteristics and outcomes.</AbstractText><AbstractText Label="MATERIALS AND METHODS.">We conducted a retrospective cross-sectional study in patients diagnosed with pulmonary or extrapulmonary tuberculosis and HIV coinfection, hospitalized in a referral institution in Bogot&#xe1; between 2019 and 2021.</AbstractText><AbstractText Label="RESULTS.">The prevalence of HIV infection in 102 patients with tuberculosis was 52.3% (54/102). Among them, 24 patients (44.4%) had microbiological or histopathological confirmation of tuberculosis infection; and 19 (35.2%) were recently diagnosed with an HIV infection. The median age of the 54 coinfected patients was 38 years (IQR: 29-42); 79.6% (43/54) were men. The median CD4+ T-cell count was 59 cells/&#x3bc;L (IQR: 32-120), and 72.2% (39/54) had a CD4+ count of less than 200 cells/&#x3bc;L; 31.4% (17/54) of patients with a history of HIV infection were receiving antiretroviral therapy. Regarding tuberculosis clinical presentation, 51.9% (28/54) had pulmonary tuberculosis, and 48.1% (26/54) had extrapulmonary tuberculosis. The extrapulmonary tuberculosis forms were meningeal (29.6%), miliary (12.9%), pleural (3.7%), and peritoneal (3.7%). The in-hospital mortality was 33.3%, associated with a low CD4<sup>+</sup> count (p &lt; 0.05), recent HIV diagnosis (p &lt; 0.04), and the presence of meningeal tuberculosis (p &lt; 0.03).</AbstractText><AbstractText Label="CONCLUSION.">The frequency of tuberculosis-HIV coinfection is high and related to an advanced degree of immunosuppression. Therefore, we recommend an active search for coinfection. Meningeal tuberculosis was the most frequent extrapulmonary form and was associated with mortality.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">tuberculosis</Keyword><Keyword MajorTopicYN="N">pulmonary</Keyword><Keyword MajorTopicYN="N">HIV</Keyword><Keyword MajorTopicYN="N">opportunistic</Keyword><Keyword MajorTopicYN="N">infections</Keyword><Keyword MajorTopicYN="N">acquired</Keyword><Keyword MajorTopicYN="N">immunodeficiency</Keyword><Keyword MajorTopicYN="N">syndrome</Keyword></KeywordList><CoiStatement><b>Conflicto de intereses:</b> Los autores declaran no tener conflictos de intereses. </CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>28</Day><Hour>7</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>27</Day><Hour>20</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>27</Day><Hour>17</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40865109</ArticleId><ArticleId IdType="pmc">PMC12448568</ArticleId><ArticleId IdType="doi">10.7705/biomedica.7664</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Murray CJL, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(1005-70) doi: 10.1016/S0140-6736(14)60844-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60844-8</ArticleId><ArticleId IdType="pmc">PMC4202387</ArticleId><ArticleId IdType="pubmed">25059949</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks SG, Overbaugh J, Phillips A, Buchbinder S. HIV infection. Nat Rev Dis Primers. 2015;1(15035) doi: 10.1038/nrdp.2015.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2015.35</ArticleId><ArticleId IdType="pubmed">27188527</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawlowski A, Jansson M, Sk&#xf6;ld M, Rottenberg ME, Kallenius G. Tuberculosis and HIV coinfection. PLoS Pathog. 2012;8(1002464) doi: 10.1371/joumal.ppat.1002464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/joumal.ppat.1002464</ArticleId><ArticleId IdType="pmc">PMC3280977</ArticleId><ArticleId IdType="pubmed">22363214</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO)   Global tuberculosis report 2024. Geneva: World Health Organization; 2024.  [18 de febrero de 2025].  Disponible en:  https://iris. who.int/bitstream/handle/10665/379339/9789240101531-eng.pdf?sequence=1
.</Citation></Reference><Reference><Citation>Letang E, Ellis J, Naidoo K, Casas EC, S&#xe1;nchez P, Hassan-Moosa R, et al. Tuberculosis- HIV co-infection: Progress and challenges after two decades of global antiretroviral treatment roll-out. Arch Bronconeumol. 2020;56:446&#x2013;454. doi: 10.1016/j.arbr.2019.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arbr.2019.11.013</ArticleId><ArticleId IdType="pubmed">35373756</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray JM, Cohn DL. Tuberculosis and HIV coinfection. Semin Respir Crit Care Med. 2013;34:32&#x2013;43. doi: 10.1055/s-0032-1333469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0032-1333469</ArticleId><ArticleId IdType="pubmed">23460004</ArticleId></ArticleIdList></Reference><Reference><Citation>Edge CL, King EJ, Dolan K, McKee M. Prisoners co-infected with tuberculosis and HIV: A systematic review. J Int AIDS Soc. 2016;19:20960&#x2013;20960. doi: 10.7448/IAS.19.1.20960.</Citation><ArticleIdList><ArticleId IdType="doi">10.7448/IAS.19.1.20960</ArticleId><ArticleId IdType="pmc">PMC5112354</ArticleId><ArticleId IdType="pubmed">27852420</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell LCK, Noursadeghi M. Pathogenesis of HIV-1 and Mycobacterium tuberculosis coinfection. Nat Rev Microbiol. 2018;16:80&#x2013;90. doi: 10.1038/nrmicro.2017.128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2017.128</ArticleId><ArticleId IdType="pubmed">29109555</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesfin YM, Hailemariam D, Biadgilign S, Kibret KT. Association between HIV/AIDS and multi-drug resistance tuberculosis: A systematic review and meta-analysis. PLoS ONE. 2013;8:e82235. doi: 10.1371/journal.pone.0082235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0082235</ArticleId><ArticleId IdType="pmc">PMC3885391</ArticleId><ArticleId IdType="pubmed">24416139</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockwood N, Wilkinson RJ. Understanding and intervening in HIV-associated tuberculosis. Clin Med (Lond) 2015;15(Suppl.6):S43&#x2013;S49. doi: 10.7861/clinmedicine.15-6-s43.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.15-6-s43</ArticleId><ArticleId IdType="pubmed">26634681</ArticleId></ArticleIdList></Reference><Reference><Citation>Fadul-P&#xe9;rez S. Protocolo de Vigilancia de Tuberculosis.  [13de junio de 2024];Instituto Nacional de Salud. 2022 :1&#x2013;33. Disponible en:  https://www.ins.gov.co/buscador-eventos/Lineamientos/Pro_Tuberculosis%202022.pdf
.</Citation></Reference><Reference><Citation>Pan American Health Organization  . Factsheet 2022: TB/HIV co-infection in the Americas. Washington D. C.: PAHO/WHO; 2022.  [18 de febrero de 2025].  Disponible en:  https://www.paho.org/sites/default/files/2023-08/2022-cde-factsheet-tb-HIV-americas.pdf
.</Citation></Reference><Reference><Citation>Ministerio de Salud y Protecci&#xf3;n Social  . Lineamiento t&#xe9;cnico operativo del Programa Nacional de Tuberculosis. Direcci&#xf3;n de Promoci&#xf3;n y Prevenci&#xf3;n. Subdirecci&#xf3;n de Enfermedades Transmisibles. Bogot&#xe1;; D.C.: 2020.  [13 de junio de 2024].  Disponible en:  https://www.minsalud.gov.co/Normatividad_Nuevo/Resoluci%C3%B3n%20No.%20227%20de%202020.pdf 
.</Citation></Reference><Reference><Citation>StataCorp . Stata Statistical Software: Release 15. College Station. Texas: StataCorp; 2017.</Citation></Reference><Reference><Citation>Ministerio de Salud  . Resoluci&#xf3;n n&#xfa;mero 8430 de 1993 por la cual se establecen las normas cient&#xed;ficas, t&#xe9;cnicas y administrativas para la investigaci&#xf3;n en salud. 1993.  [13 de junio de 2024].  Disponible en:  https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/RESOLUCION-8430-DE-1993.pdf
.</Citation></Reference><Reference><Citation>Frieden TR, Harold Jaffe DW, Moran JS, Leahy MA, Martinroe JC, Spriggs SR, et al. Revised surveillance case definition for HIV Infection - United States, 2014. Vol. 63. MMWR Recomm Rep; 2014. pp. 1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">24717910</ArticleId></ArticleIdList></Reference><Reference><Citation>Joint United Nations Programme on HIV/AIDS (UNAIDS)   In danger: UNAIDS Global AIDS Update 2022. Geneva: UNAIDS; 2022.  [13 de junio de 2024].  Disponible en:  https://www.unaids.org/sites/default/files/media asset/2022-global-aids-update en.pdf
.</Citation></Reference><Reference><Citation>Kawatsu L, Uchimura K, Kaneko N, Imahashi M. Epidemiology of coinfection with tuberculosis and HIV in Japan, 2012-2020. West Pac Surveill Response J. 2022;13:1&#x2013;8. doi: 10.5365/wpsar.2022.13.1.896.</Citation><ArticleIdList><ArticleId IdType="doi">10.5365/wpsar.2022.13.1.896</ArticleId><ArticleId IdType="pmc">PMC9016268</ArticleId><ArticleId IdType="pubmed">35494412</ArticleId></ArticleIdList></Reference><Reference><Citation>Zohar M, Moshe L, Daniel C, Noa C, Itamar G. HIV prevalence in the Israeli tuberculosis cohort, 1999-2011. BMC Public Health. 2014;14:1090&#x2013;1090. doi: 10.1186/1471-2458-14-1090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-14-1090</ArticleId><ArticleId IdType="pmc">PMC4221682</ArticleId><ArticleId IdType="pubmed">25335562</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Regional Office for Europe, European Centre for Disease Prevention and Control  . HIV/AIDS surveillance in Europe 2024-2023 data. Copenhagen: WHO Regional Office for Europe; 2024.  [18 de febrero de 2025].  Disponible en:  https://www.ecdc.europa.eu/sites/default/files/documents/HIV_Surveillance_Report_2024.pdf
.</Citation></Reference><Reference><Citation>Cuenta de Alto Costo (CAC)   Situaci&#xf3;n del HIV en Colombia 2024. Bogot&#xe1;, D. C.: Fondo Colombiano de Enfermedades de Alto Costo; 2025.  [18 de febrero de 2025].  Disponible en:  https://cuentadealtocosto.org/publicaciones/situacion-del-HIV-en-colombia-2024/
</Citation></Reference><Reference><Citation>Cort&#xe9;s JA, Hidalgo P, Rey DL, Parra GA, Guti&#xe9;rrez IF. Tuberculosis en pacientes con infecci&#xf3;n por VIH en el Hospital Universitario de San Ignacio, 2002-2006. Infectio. 2007;11:16&#x2013;22.</Citation></Reference><Reference><Citation>Ruiz L, Maya MA, Rueda ZV, L&#xf3;pez L, V&#xe9;lez LA. Current characteristics of tuberculosis and human immunodeficiency virus co-infection in a cohort of hospitalized patients in Medell&#xed;n, Colombia. Biom&#xe9;dica. 2018;38:59&#x2013;67. doi: 10.7705/biomedica.v38i3.3862.</Citation><ArticleIdList><ArticleId IdType="doi">10.7705/biomedica.v38i3.3862</ArticleId><ArticleId IdType="pubmed">30184364</ArticleId></ArticleIdList></Reference><Reference><Citation>Tancredi MV, Sakabe S, Waldman EA. Mortality and survival of tuberculosis coinfected patients living with AIDS in S&#xe3;o Paulo, Brazil: A 12-year cohort study. BMC Infect Dis. 2022;22:223&#x2013;223. doi: 10.1186/s12879-022-07232-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07232-6</ArticleId><ArticleId IdType="pmc">PMC8897065</ArticleId><ArticleId IdType="pubmed">35246066</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanhueza-Sanzana C, Kerr L, Kendall C. Mortality from AIDS and tuberculosis- HIV coinfection in the Chilean AIDS Cohort of 2000-2017. Cad Sa&#xfa;de P&#xfa;blica. 2021;37:e00212920. doi: 10.1590/0102-311X00212920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0102-311X00212920</ArticleId><ArticleId IdType="pubmed">34190832</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a I, Merch&#xe1;n A, Chaparro PE, L&#xf3;pez LE. Panorama de la coinfecci&#xf3;n tuberculosis/HIV en Bogot&#xe1;, 2001. Biom&#xe9;dica. 2004;24(Supl.1):132&#x2013;137. doi: 10.7705/biomedica.v24iSupp1.1312.</Citation><ArticleIdList><ArticleId IdType="doi">10.7705/biomedica.v24iSupp1.1312</ArticleId><ArticleId IdType="pubmed">15495581</ArticleId></ArticleIdList></Reference><Reference><Citation>Mont&#xfa;far Andrade FE, Villa Franco P, Mont&#xfa;far Pantoja MC, Zuleta Tob&#xf3;n JJ, P&#xe9;rez Jaramillo LE, Monsalve Valencia MA, et al. Coinfecci&#xf3;n por virus de inmunodeficiencia humana y micobacterias en un hospital universitario de alta complejidad en Colombia. Infectio. 2016;20:158&#x2013;164. doi: 10.1016/j.infect.2015.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.infect.2015.05.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Joint United Nations Programme on HIV/AIDS (UNAIDS)  Global HIV &amp; AIDS statistics - Fact sheet 2024. Geneva: UNAIDS; 2024.  [19 de febrero de 2025].  Disponible en:   https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf 
.</Citation></Reference><Reference><Citation>de Vries G, van de Berg S, van Dam A, Hasanova S, Pareek M, van der Werf MJ, et al. Collaborative tuberculosis/HIV activities in the European Region. ERJ Open Res. 2021;7:00721&#x2013;02020. doi: 10.1183/23120541.00721-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00721-2020</ArticleId><ArticleId IdType="pmc">PMC7836583</ArticleId><ArticleId IdType="pubmed">33532469</ArticleId></ArticleIdList></Reference><Reference><Citation>Abay SM, Deribe K, Reda AA, Biadgilign S, Datiko D, Assefa T, et al. The Effect of early initiation of antiretroviral therapy in TB/HIV-coinfected patients: A systematic review and meta-analysis. J Int Assoc Provid AIDS Care. 2015;14:560&#x2013;570. doi: 10.1177/2325957415599210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2325957415599210</ArticleId><ArticleId IdType="pubmed">26289343</ArticleId></ArticleIdList></Reference><Reference><Citation>Plata-Casas L, Guti&#xe9;rrez-Lesmes O, Herr&#xe1;n-Falla O. Infecci&#xf3;n concomitante por tuberculosis y el virus de la inmunodeficiencia humana: situaci&#xf3;n epidemiol&#xf3;gica en el departamento del Meta, 2010-2015. Biom&#xe9;dica. 2018;38:68&#x2013;79. doi: 10.7705/biomedica.v38i3.3930.</Citation><ArticleIdList><ArticleId IdType="doi">10.7705/biomedica.v38i3.3930</ArticleId><ArticleId IdType="pubmed">30184365</ArticleId></ArticleIdList></Reference><Reference><Citation>Rindi L. Rapid molecular diagnosis of extra-pulmonary tuberculosis by Xpert/RIF ultra. Front Microbiol. 2022;13:817661&#x2013;817661. doi: 10.3389/fmicb.2022.817661.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.817661</ArticleId><ArticleId IdType="pmc">PMC9130774</ArticleId><ArticleId IdType="pubmed">35633667</ArticleId></ArticleIdList></Reference><Reference><Citation>Seddon JA, Tugume L, Solomons R, Prasad K, Bahr NC. Tuberculous Meningitis International Research Consortium. The current global situation for tuberculous meningitis: Epidemiology, diagnostics, treatment and outcomes. Wellcome Open Res. 2019;4:167&#x2013;167. doi: 10.12688/wellcomeopenres.15535.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.15535.1</ArticleId><ArticleId IdType="pmc">PMC7029758</ArticleId><ArticleId IdType="pubmed">32118118</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchini D, Ambrosioni J, Brezzo C, Corti M, Rybko A, P&#xe9;rez M, et al. Tuberculous meningitis in HIV-infected and non-infected patients: Comparison of cerebrospinal fluid findings. Int J Tuberc Lung Dis. 2009;13:269&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pubmed">19146759</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>